Humacyte Inc Warrant
HUMAW
7 hedge funds and large institutions have $46.1K invested in Humacyte Inc Warrant in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
8% less capital invested
Capital invested by funds: $49.9K → $46.1K (-$3.82K)
13% less funds holding
Funds holding: 8 → 7 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$128 |
| 2 |
LPL Financial
San Diego,
California
|
+$57 |
| 3 |
Jane Street
New York
|
+$23 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3.53K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$368 |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$84 |
HUMAW Hedge Fund Activity: Q1 2026 in Review
7 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Humacyte Inc Warrant (HUMAW) for Q1 2026, worth a combined $46.1K — down 7.7% from $49.9K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of HUMAW and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 3 added.
The largest buyer was Wolverine Asset Management, adding an estimated $128. The largest seller was Susquehanna International Group, cutting an estimated $3.53K.
- 7 institutional investors held Humacyte Inc Warrant (HUMAW) as of Q1 2026, down from 8 in Q4 2025.
- Funds reported $46.1K of Humacyte Inc Warrant stock for Q1 2026, down 7.7% quarter-over-quarter.
- 0 funds opened new Humacyte Inc Warrant positions in Q1 2026 and 1 closed out, a net change of -1 holder.
- The largest Humacyte Inc Warrant buyer in Q1 2026 was Wolverine Asset Management, an estimated $128 added.
- The largest Humacyte Inc Warrant seller in Q1 2026 was Susquehanna International Group, an estimated $3.53K sold.
Based on aggregated 13F filings for Q1 2026.